Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China flag China · Delayed Price · Currency is CNY
34.17
-1.18 (-3.34%)
Apr 29, 2026, 3:04 PM CST
Market Cap6.93B +152.5%
Revenue (ttm)1.42B -7.4%
Net Income125.44M +56.1%
EPS0.62 +55.0%
Shares Out196.11M
PE Ratio57.02
Forward PEn/a
Dividend0.20 (0.57%)
Ex-Dividend DateNov 24, 2025
Volume15,796,605
Average Volume26,692,116
Open39.00
Previous Close35.35
Day's Range34.15 - 39.00
52-Week Range13.25 - 68.80
Beta0.80
RSI48.32
Earnings DateApr 29, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 1,275
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002940
Full Company Profile

Financial Performance

In 2025, SHE:002940's revenue was 1.42 billion, a decrease of -5.84% compared to the previous year's 1.51 billion. Earnings were 125.44 million, an increase of 56.15%.

Financial Statements